Title: Announcement of new division: C9 – Biomedical, Health-Beneficial, and Nutritionally Enhanced Plants Authors
|Westgate, Mark -|
Submitted to: Crop Science
Publication Type: Other
Publication Acceptance Date: August 15, 2009
Publication Date: October 1, 2009
Citation: Westgate, M.E., Grusak, M.A. 2009. Announcement of new division: C9 – Biomedical, Health-Beneficial, and Nutritionally Enhanced Plants. Crop Science. 49:vii. Technical Abstract: Crop Science, is pleased to announce that manuscript submissions are now being accepted to the journal through the new Provisional Division C09 – Biomedical, Health-Beneficial, and Nutritionally Enhanced Plants. The focus of this Division is on plants as food or feed, and on the development and evaluation of novel characteristics, and compositional quality traits in crops that are important to the health, well being, and nutritional requirements of humans. The Editors at Crop Science look forward to providing CSSA members a venue for publishing research in this area, and to providing its readership with timely and informative reports in this interdisciplinary aspect of crop science. Although the Editors anticipate receiving manuscripts with an overriding focus on crops for improved human nutrition or health, they expect and would welcome research coming from diverse disciplines. Possible areas of disciplinary focus could include conventional breeding; transgenic modification; germplasm evaluation; or clinical, animal, or cell culture studies that evaluate crop products. Possible areas of health or nutrition focus might include essential nutrients (e.g., vitamins, minerals, protein, lipids, and energy components); health-beneficial phytochemicals; anti-nutrients; bioactive compounds; or nutraceuticals. Possible targets of improvement for the harvested crop product could include: contribution of the food crop to meeting the Recommended Dietary Allowance (RDA), or Daily Reference Intake (DRI) of a given nutrient; improving anti-oxidant status; prevention of cancer; reducing disease risk; or as a possible therapy in disease treatment.